Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
MVEuNWWm7StdZXBH
